Montclair State University

Montclair State University Digital
Commons
Theses, Dissertations and Culminating Projects
1-2023

Optimizing CRISPR/Cas9 Transfection Protocol to Generate a Teton Inducible Sk-Mel 24 Cell Lines to Better Study ICER
Abdulkader Hallak

Follow this and additional works at: https://digitalcommons.montclair.edu/etd
Part of the Biology Commons

1
Abstract
Inducible cAMP Early Repressor (ICER) is a dominant transcription repressor of the
cAMP Responsive Element Modulator (CREM) and cAMP Responsive Element Protein (CREB)
family of transcription factors. ICER isoforms are differently expressed in various cell types and
are involved in essential functions including hormonal regulation, circadian rhythm,
spermatogenesis, and immune response. In the context of cancer, ICER is proposed as a tumor
suppressor in leukemia, prostate, pituitary cancers, and melanoma. In melanoma, ICER is
targeted for degradation during tumorigenesis and highly upregulated during regression, further
highlighting its potency as a tumor suppressor. Inside the nucleus, ICER targets oncogenes and
key cell-cycle regulatory genes such as Cyclin A, Cyclin D, C-fos and Bcl2, yet the full
spectrum of its targets has not been fully explored.
The goal of this thesis is to generate a stable inducible cell line which allows better study
of ICER at viable conditions, identifying its binding regions and any additional genes it targets.
For this study Sk-Mel-24 cells were used as a model of human melanoma. Two plasmids were
utilized in each transfection round, all-in-one Cas9 gRNA plasmid and an ICER-containing
donor DNA plasmid. The Cas9 gRNA plasmid was used to target the AAVS1 (safe harbor)
locus, due to the transcriptional competence and minimal adverse effect of the region. As for the
donor plasmid, it carried N-terminus hemagglutinin (HA) tagged ICER ( HA-ICER) under the
N

control of Tetracycline-induced expression system. Results from Western blot,
immunocytochemistry (ICC), fluorescence microscopy all demonstrate successful doxycycline
induction. Furthermore, PCR and sanger data proper integration of HA-ICER into the AAVS1
N

locus.
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Introduction:
Inducible Cyclic AMP Early Repressor (ICER) is a small DNA binding protein and
transcription factor that is well involved in cellular functions such as hormonal regulation,
circadian rhythm, spermatogenesis, immune response, and other metabolic functions as well.
ICER is a collective name given to four different isoforms, all which originate from the intronic
P2 promoter within the CREM gene via alternative splicing (Molina et al., 1993). ICER isoforms
consist of conserved N-terminus domain encoded by exon X, followed by a gamma domain
encoded by exon gamma (present in ICER I & ICER II and absent in ICER I-gamma & ICER IIgamma), a basic domain encoded by domain H, and a leucine zipper domain encoded by exon I.
ICER I & ICER II differ in their exon I sequence giving the two isoforms different DNA binding
affinity (Molina et al., 1993) & (Kaprio et al., 2021). The basic domain followed by the leucine
zipper forms a DNA binding domain which allows ICER to form dimers while binding DNA.
Under normal conditions, second messengers of the cyclic adenylyl cyclase pathway,
such as protein kinase A (PKA), phosphorylate both Cyclic AMP Response Element Binding
(CREB) and CREM proteins, both which function as transcription activators of CRE containing
genes (Steven et al., 2020). ICER on the other hand, although induced through the same
pathway, functions as a dominant transcription repressor by targeting cAMP responsive genes
which contain cAMP Responsive Element (CRE) sequence in their promoters, TGACGTCA for
example (Laoide et al., 1993). Interestingly, four CRE elements exist in tandem in the P2
promoter, which allows ICER to bind those sequences and autoregulate its own transcription in a
negative feedback fashion (Molina et al., 1993).
In terms of physiology, ICER is most known as a potent tumor suppressor (Pigazzi et al.,
2008) as it blocks cells in the G1/S (Greco et al., 2017) and G2/M checkpoints (Lamas et al.,
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1997). ICER controls those checkpoints by repressing the expression of certain key proteins
which are involved in cell cycle regulation such as Cyclin A, Cyclin D and c-fos (Steigedal et al.,
2007). Transfection studies using corticotropic cell lines by Lamas et al. (1997) shows that
Cyclin A expression was completely absent, and the cells were blocked at the G2/M checkpoint
upon expressing sense ICER transcript. It is not surprising, considering that Cyclin A promoter
contains a CRE sequence and has been shown to be responsive to adenylyl cyclase pathway
signaling (Desdouets et al., 1995).
Another study by Muñiz et al. (2006) demonstrates that Cyclin D2 is regulated, at the
transcription level, via a cAMP-PKA-dependent pathway in response to FSH signaling via a
CRE element in the promoter. This signaling system, which signals for the progression of the
cell cycle towards the DNA synthesis phase, was completely absent in granulosa cells which
received ICER treatment, locking the cells at the G1/S checkpoint and preventing the cells from
entering the S phase.
In addition to halting cell cycle progression, ICER also induces apoptosis in melanoma
(Tomita et al., 2003; Cirinelli et al., 2022) although the mechanism is not fully understood.
Melanoma is a rare malignancy that develops in the pigment producing tissues of the skin, also
known as melanocytes and is responsible for a vast majority of cancer deaths in the U.S (Garbe
et al., 2016). Interestingly, ICER is significantly downregulated in melanoma, not at transcription
level but rather at the protein level. In 2013, Healey et al. show that increased H-RasV12G
levels, a key protein for the progression and maintenance of melanoma, induce ICER’s ubiquitinmediated degradation while ICER mRNA levels were unaffected. An example of this posttranslational modification of ICER has been previously demonstrated as ICER can be mono- or
poly-ubiquitinated, which lead to its translocation from the nucleus or degradation by
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proteasome, respectively, both which cause loss of function of the transcription factor (Yehia et
al., 2001). In summary, we have a basic understanding of ICER’s down regulation in melanoma,
but very limited knowledge on the full spectrum of ICER’s target genes and its relation to
tumorigenic phenotype. Taken together, we hypothesize that ICER, as a transcription factor,
targets and represses multiple key oncogenes and other key cell-cycle regulating genes.
To further investigate this claim, it was necessary to generate model cell lines with
controlled expression of ICER at defined levels, high enough to detect the effects on target genes
and low enough for the cells to remain viable and minimize the lethal effects of ICER. A plan
was devised to generate an inducible ICER-expressing vector using the Tet-on operon. Tet-on
system was first introduced by (Goosen & Bujard. 1992). By fusing the tetracycline repressor
tetR region of E. Coli with the activating region of Virion protein of the HSV virus, Goosen &
Bujard (1992) were able to generate a tetracycline-inducible expression system. In the presence
of tetracycline, a hybrid transactivator is produced which functions to stimulate the promoter of
the tetracycline Operator (tetO) and initiate transcription. Tet-on system not only functions as an
“on/off” switch but is also sensitive to tetracycline levels which can modulate the transcription
levels, up to five orders of magnitude (Goosen & Bujard. 1992). The Tet-on system with its
bacterial origin also provides an advantage in that the system relies minimally, if at all, on
eukaryotic endogenous control elements, which is a common problem in eukaryotic inducible
systems, thus, providing maximal control over transcription.
To ensure a successful integration and minimal side effects, we picked AAVS1, also
known as the “safe harbor” region as our integration site. In human chromosome 19, PPP1R12C
(protein phosphatase 1 regulatory subunit 12C) gene is a common integration site for the AdenoAssociated Virus (AAV) (Kotin et al., 1992), hence the name AAVS1. Normally, PPP1R12C
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has an active promoter and is constantly expressed in all cell types (See Figure), and commercial
cell lines. Furthermore, no known pathophysiology was associated with PPP1R12C disruption
via AAV infection (Smith et al., 2008). Furthermore, integration at this site will help us avoid
random gene silencing and/or common epigenetic modifications associated with traditional
integration protocols (Tiyaboonchai et al., 2014). Both the transcriptional competence and
minimal adverse effect of disrupting the gene make AAVS1 a great candidate for this study.
Figure 1
PPP1R12C RNA expression in eukaryotic cells

The diagram above illustrates PPP1R12C RNA expression across all eukaryotic cell types,
diagram produced by protein Atlas: https://www.proteinatlas.org
Finally, the CREM gene, the source of ICER transcripts, was left unmodified in our cell
lines to avoid interfering with the physiological functions of the other gene products, such as the
CREM protein for example. In order to distinguish endogenous from exogenous ICER
expression we decided to use a hemagglutinin tag (HA) tag at the N-terminus sequence of our
ICER. Hemagglutinin, also referred to as the “HA” tag is a well characterized epitope tag that is
commonly used for molecular labeling purposes and has no known effects on protein function.
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As a matter of fact, a recent study by Cirinelli et al. (2022) shows that HA-ICER is more
N

tolerant to ubiquitin-directed degradation compared to the non-tagged ICER.
Material and Methods:
Plasmid Construction:
AAVS1 Safe Harbor Site Targeting All-purpose HR Donor Vector 2.0 (AAVS1-SApuro-MCS) by (System Bioscience, Ca) was used as the donor DNA for our homology
recombination approach. The construct came in with a built-in Puromycin resistance cassette, 3’
& 5’ homology arms, and a multiple cloning site (MCS). A separate Tet-One™ Inducible
Expression vector with a hPGK promoter was purchased from Takara Bio, Japan (Figure 2.1). Nterminus HA-tagged ICER ( HA-ICER) cDNA plasmid was subcloned into the Tet-One vector
N

which was subcloned into the AAVS1 donor vector comprising the final donor plasmid (see
figures 2.2 & 2.3). For CRISPR, all in one pCas9 plasmid was purchased from (System
Bioscience, Ca) with the following gRNA (5’-GTCCCCTCCACCCCACAGTG-3’).
Figure 2.1
Original Tet-One™ Inducible vector by Takara Bio

Circular diagram of the original (unmodified) Tet-One™ Inducible Expression vector by
Takara Bio, Diagram produced by Snap Gene.
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Cell Culture/Transfection:
Commercially available Human melanoma SK-MEL24 by (ATCC, US) were purchased
and cultured in 35 mm 6-well plate following the manufacturer’s recommendation. Cells were
grown in Eagle's Minimum Essential Medium (EMEM) media (ATCC, US) with 10%
tetracycline-free Fetal Bovine Serum (FBS) following the suppliers’ guidelines. For transfection
protocols, pure EMEM media was used in absence of FBS and/or antibiotics. For this
experiment, FuGENE® HD Transfection Reagent kit (Promega, US) was used. Each reaction
contained transfection Media, pCas9-GFP plasmid, HA-ICER plasmid (eGFP for control), and
N

FuGene reagent. All transfection reagents and plasmids were mixed in 2 mL tubes, then
transferred to 35 mm well plates. Cell lines were then incubated for two hours with the
transfection reagents, before changing the media once again. At 70 – 80 % confluency post
transfection (2-3 days), cells were treated with puromycin for a final concentration of 0.5 ul/mL
in media to select for the transfected colonies. It took roughly 30 days before colonies were
formed after puromycin treatment. Surviving colonies were then labeled and frozen for later WB
and PCR analysis. For the purposes of this study, Sk-Mel 24 cells were also transfected with
eGFP and served as control group.
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Figure 2.2
linear Tet-on/HA-ICER construct with the AAVS1 homology arms

Linear diagram of the modified Tet-on/ HA-ICER construct with the AAVS1 homology
arms, diagram produced by Snap Gene
Figure 2.3
N

circular Tet-on/HA-ICER construct with the AAVS1 homology arms

Circular diagram of the modified Tet-on/NHA-ICER construct with the AAVS1 homology
arms, diagram produced by Snap Gene
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Western Blot & Immunocytochemistry (ICC):
Selected colonies were collected at near 80 – 90 % confluency for WB analysis. First,
cells were washed using Phosphate buffer saline (PBS) then incubated in Trypsin for 3 minutes
at room temperature. Trypsin was then washed, and 1mL of EMEM+FBS+penicillin media was
added to the cell. Tubes were then centrifuged at 300g for 6 minutes to collect cellular fractions.
SDS-Page was then followed by Western Blot following Cirinelli et al. (2022) and the antibodies
supplier recommendation. The detection and analysis of western blot was performed using
IRDye® secondary antibodies and imaged using the Odyssey CLX infrared system. For primary
antibodies, rabbit anti-HA tags were used to ONLY detect exogenous ICER expression
(Invitrogen, US).
For ICC, selected colonies were washed with PBS before fixating in 4% formaldehyde
for 20 minutes. Cells were then washed again with PBS and preheated antigen retrieval buffer
(1X NaCitrate pH 8.0) was added and incubated for 10 minutes at 95 C. Cells were then
separated from the buffer, washed, and incubated in 0.1% Triton X-100 in PBS for 15 minutes at
room temperature. All excess PBS was removed before applying the protein block to block
nonspecific binding for 1 hour at room temperature. Mouse anti-HA primary antibodies (Alexa
Fluor 594 by Thermofisher) were applied for a final concentration of 1.0 μg/ml, and cells were
incubated overnight at 4 C. Cells were then washed again the following morning and allowed to
dry at room temperature for 1 hour. One mounting drop was added to each slide and covered
with a cover slip before imaging with Nikon® Eclipse Ti inverted fluorescent microscope.
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PCR & Sequencing:
PCR was carried out using the Dream Taq Green kit by Thermofischer following the
manufacturer’s guidelines. The primers (Forward: 5’-CTCAGTCTGAAGAGCAGAGC-3’;
Reverse: 5’-CCACTGTTTCCCCTTCCCAG-3’) were designed in house and purchased from
System Bioscience, Ca. Gel electrophoresis was performed in 1% agarose gel with 10ul of
sample in each well. Bands at the region of interest were then excised and sent for sanger
sequencing.
Results:
Successful eGFP expression 48 hours post doxycycline induction:
The first step was to evaluate our protocol by checking for fluorescence signal in the
negative control groups. After transfection and puromycin selection, it took roughly 30 days for
cells to reach confluency of 70-80 % before inducing with doxycycline. Surviving colonies then
received doxycycline treatment, incubated and monitored periodically for maximal fluorescence
response. Control Sk-Mel24

eGFP

(Figure 3) colony for example, showed successful and maximal

eGFP induction 48 hours after receiving doxycycline, compared to no fluorescing at all in the
absence of doxycycline. Interestingly, increasing doxycycline had no response on fluorescence
intensity (data not shown).
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Figure 3
Sk-Mel24eGFP control colony before and after doxycycline induction

Sk-Mel24eGFP colony before (left) and after (right) receiving doxycycline treatment under
fluorescence microscope at (40x). Right image (after) was taken 48 hours after adding
doxycycline
Western Blot indicates successful doxycycline induction:
Like the control colony, selected HA-ICER colonies with decent confluency received
N

doxycycline treatment and were incubated for 48 hours before proceeding to WB. Colonies 459

B

and 459 were the only surviving HA-ICER containing colonies (459 was a false positive). It is
C

N

A

important to note that anti-HA primary antibodies were used in this experiment to avoid
incorporating endogenous ICER in the evaluation of this procedure. In figure 4, we see a clear
decent band in lanes 2 & 4 which correspond to colonies 459 & 459 , respectively, both which
B

C

received a single doxycycline treatment. Although the band is in the approximately 17 kD
region, which is slightly higher than ICER’s molecular weight of 13.5 kD, the fusion of HA tag
along with ICER being positively charged can explain this deviation. Additionally, that same 17
kD band is completely absent in colonies 459 (lane 3) & 459 (lane 5) which did not receive any
B

C

doxycycline treatment. For our control, lanes 6 & 7, corresponding to induced eGFP & noninduced eGFP respectively, both which lack the HA-ICER construct, no bands have been
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observed in the expected region. Finally, lanes 8 & 9 correspond to induced colonies 459 and
B

459 (same doxycycline dose) where double the sample volume was loaded to the gel just to
C

compare signal intensity.
Figure 4
Western Blot analysis of colonies 459B, 459C, & Sk-Mel24eGFP

Western blot confirms for the presence of HA-ICER (17 kD) in colonies 459 B & 459C after
receiving doxycycline treatment while completely absent in the eGFP colony. A (+) sign
indicates receiving a single dose of doxycycline and a (-) indicates not receiving a treatment
at all. Lanes 2, 3 & 8 correspond to colony 459B. Lanes 4, 5, & 9 correspond to colony 459C.
Lanes 6 & 7 correspond to eGFP colonies.
Immunocytochemistry confirms the presence of HA tags in the nucleus of selected colonies:
Fluorescence microscopy post ICC was performed to confirm the presence and
localization of HA tags in the selected colonies. For additional control in this experiment, SkMel cells were transiently transfected with HA-ICER and compared against colonies 459 &
N

B
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459 (Figure 5). In transient transfection, exogenous DNA is delivered to a limited number of
C

cells which end up expressing HA-ICER, but do not pass on this DNA to their progenitors, in
contrast to colonies 459 & 459 which are expected to express HA-ICER in all their cells. Figure
B

C

5 below shows transiently transfected Sk-Mel (left), 459 (middle), and 459 (right) 48 hours
B

C

after receiving doxycycline treatment. It is apparent that HA tags were present in both 459
colonies, and to a much lesser extent in transiently transfected Sk-Mel cells, and mostly within
the nucleus, which is to be expected considering that ICER is a nuclear factor and a DNAbinding protein.
Figure 5
Immunocytochemistry (ICC) analysis of colonies transiently transfected Sk-Mel , 459 B, & 459C

Immunocytochemistry using anti-HA antibodies confirm the presence of HA tags in
transiently transfected Sk-Mel (left), 459B (middle), and 459C (right), microscopic images
were taken at (10x) 48 hours post doxycycline treatment.
PCR and sanger sequencing confirm successful integration in the safe harbor:
All the previous experiments have indicated a successful induction of HA-ICER upon
doxycycline treatment. However, to confirm that this response is indeed due to successful
integration of the construct within the safe harbor, PCR was performed as mentioned in the
methods section. The primers that were used were specifically targeting the overlap between the
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safe harbor region in the genome and the HA-ICER cDNA sequence that we have previously
subcloned and transfected into Sk-Mel24 cells. Using SnapGene software, a PCR product of
flanking overlap between the two AAVS1 homology arms of our final construct is expected to be
around 1750bp. Both colonies 459 & 459 underwent PCR in replicates to ensure proper
B

C

amplification. Interestingly, all four replicates, (459 in lanes 3/4 and 459 in lanes 6 /7) have
B

C

produced fragments around the 3500bp region (explicit data not shown). DNA from each of
these band was excised separately and underwent a second round of PCR to produce bands with
correct length of 1750bp in figure 6.
Figure 6
Gel electrophoresis of PCR products of colonies 459B & 459C

Colonies 459B (lanes 3&4) and 459C (lanes 6 & 7) underwent polymerase chain reaction
(PCR) then electrophoresed in 1% agarose gel. All four replicates produced the expected
band around 1750 bp along with a non-specific band around the 3500 bp region.
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Following PCR, Sanger sequencing was the next and final experiment to confirm proper
integration of our designed construct. PCR product of 459 (lane 3, figure 6) was excised and
B

sent for sanger sequencing. Sequencing results were then analyzed and aligned against HAN

ICER cDNA sequence in SnapGene software and showed perfect alignment (data not shown).
Discussion:
Inducible Cyclic AMP Early Repressor (ICER) is a transcription factor that targets key
cell-cycle regulating genes. Although the full spectrum of ICER targets has been fully explored,
yet it has been proposed as a potent tumor suppressor in many cancer types including leukemia
(Pigazzi et al., 2008), prostate (Mémin et al., 2002) and pituitary cancers (Peri et al., 2001).
Additionally, in melanoma, ICER is completely down regulated during tumor genesis and is
upregulated during regression (Healey et al., 2013). A major challenge, however, when
attempting to study ICER is its low baseline levels in healthy individuals and its lethal effects
when in higher concentrations in cancerous cells. Previous attempts to study the protein using
transient transfection method have yielded short-lived cell lines. In this thesis, the goal was to
generate stable, reliable, and inducible cell lines to control ICER expression within viable levels
using Sk-Mel-24 cells as a model to study human melanoma.
Melanoma is a rare, lethal, and highly mutated form of skin malignancy. In melanoma,
upregulation of Ras/MAPS signaling pathway has been implicated with ICER down regulation at
the protein level as the levels of mRNA remain unaffected. In that same study, Healey et al.
(2013) show that ICER is negatively regulated by H-RasV12G, a key inducer of melanoma
genesis, via polyubiquitination followed by proteasomal degradation. Moreover, ICER can also
be monoubiquitinated at key lysine residues which leads to its translocation from the nucleus to

22
the cytoplasm and thus loss of function (Mémin et al., 2011). Considering that ICER lacks the Pbox domain, a signature phosphorylation site for members of its family, ubiquitin-mediated
regulation is the main method of controlling ICER’s activity (Folco & Koren, 1997). In addition
to generating stable and inducible cell lines, it was equally important to prolong the life of ICER
inside the nucleus through the addition of hemagglutinin (HA) tag to the N-terminus. A recent
study by Cirinelli et al. (2022) has shown that the addition of hemagglutinin (HA) tag to ICER
N-terminus increases its efficiency and increases its resistance to ubiquitination as the latter
process follows the N-terminal rule.
The final construct which was used in this study was an expression vector which
contained NHA-ICER cDNA under the inducible regulation of the system which was
successfully integrated in the safe harbor region. Both experimental colonies, 459B & 459C (and
control eGFP colony) were successfully induced to express upon doxycycline treatment. It is
worth noting that Anti-HA antibodies were used in this experiment, indicating that present bands
correspond to exogenous HA-ICER and do not account for endogenous expression. Although the
present bands were slightly higher on the scale, 17.5 kD compared to 13.5 kD MW of ICER, but
that could be in part explained considering the fusion HA tag along with positive charge of
ICER. Another explanation for this could be ICER’s interaction with other proteins. It has been
recently reported that ICER has direct interactions with over 28 proteins in Sk-Mel-24 cells to
varying extents (Cirinelli et al., 2022). For future WB experiments, it would be more beneficial
to use fluorescence-labeled anti-HA primary antibodies as the combination of antibodies used in
this experiment produced unspecific background bands. It is worth noting that those unidentified
bands were consistently present in non-induced and in control colonies as well further imply
their non-specificity,
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Although western blot analysis confirmed successful doxycycline induction, it was
equally important to confirm that the HA-ICER had successfully integrated in the safe harbor
N

location and not in any other region in the genome. Using primers designed to target the overlap
of AAVS1 homology arms and their designated integration site in the genome, PCR results
confirm that our construct had integrated successfully. Furthermore, the puromycin resistance
gene in the final construct used in this study (figures 2.2 & 2.3) has no built-in promoter and
relies on an endogenous PPP1R12C promoter in the safe harbor locus. Having this extra layer of
control would have been sufficient to rule out random integration.
The completion of this project lays the foundation for future experiments and allows for
up scaling the research process. By the end of this report, all presented data suggest that our
HA-ICER has been successfully integrated into the safe harbor location and has been responsive

N

to doxycycline induction as planned. The next step in this project would be to generate a doseresponse curve and evaluate Sk-Mel-24 cells’ tolerance against HA-ICER. Following that, RNA
N

sequencing experiments can begin under the newly established viable ICER levels.
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